Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPanthera Res. Regulatory News (PAT)

Share Price Information for Panthera Res. (PAT)

Share Price is delayed by 15 minutes
Get Live Data
18.25    0.05 (0.27%)
Bid:
18.00
Ask:
18.50
Spread: 0.50 (2.778%)
Market Cap: £47.25m
PAT Live PriceLast checked at - London Stock Exchange

Intraday Panthera Res. Share Chart

Equity Financing

15 May 2020 14:46

RNS Number : 0970N
Panthera Resources PLC
15 May 2020
 

15 May 2020

 

Panthera Resources Plc

("Panthera" or "the Company")

 

Equity Financing

 

Panthera Resources plc (AIM: PAT), the gold exploration and development company with assets in India and West Africa, is pleased to announce it has arranged an equity financing with existing and new investors for £349,390 ("Equity Financing").

 

The Equity Financing comprises the issue of 9,494,296 new ordinary shares ('Ordinary Shares') in the Company at a price of 3.68 pence per Ordinary Share. In addition subscribers will also receive one warrant for every two Ordinary Shares subscribed for, exercisable at a price of 6.68 pence on or before 16 December 2021 (the 'Warrant'), with each Warrant entitling the holder to acquire one new Ordinary Share upon exercise of the Warrant. In aggregate 4,747,149 Warrants will be issued as part of the Equity Financing.

 

The 9,494,296 new Ordinary Shares are expected to be admitted to trading on AIM on or around 22 May 2020 ('Admission'). Following Admission, the Company will have 84,705,047 Ordinary Shares in issue.

 

For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules ("DTRs"), the issued Ordinary Share capital of Panthera following this allotment consists of 84,705,047 Ordinary Shares with voting rights attached (one vote per share). There are no shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, Panthera under the DTRs.

 

Variation to RIM Financing Agreement

 

Republic Investment Management Pte Ltd ('RIM') has participated in £236,226 of the Equity Financing under a variation to the existing subscription agreement.

 

Pursuant to the existing subscription agreement between the Company and RIM, and the subsequent variation as announced on 8 August 2019, RIM agreed to subscribe to A$1,763,789 in Ordinary Shares of the Company to be priced at a 15% discount to the 20 day VWAP at that time ("Tranche 3B"). Tranche 3B is conditional upon receipt of approvals to recommence exploration at the Bhukia JV project in India.

 

The Company advises that it has now entered into a further variation agreement reducing the RIM Tranche 3B subscription by A$448,728, being RIM's participation in the current Equity Financing. Following the variation, Tranche 3B is reduced from A$1,763,789 to A$1,315,061.

 

Certain Directors also participated in the Equity Financing. Details of the shares purchased by Directors are as follows: 

 

Name

Title

Price per share

Number of shares purchased

Shares held after purchase

% holding post purchase

Michael Higgins

Non Executive Chairman

3.68p

705,000

8,387,808

9.90%

Mark Bolton

Managing Director

3.68p

350,000

350,000

0.41%

Timothy Hargreaves

Non Executive Director

3.68p

286,739

1,918,534

2.26%

 

Mark Bolton, Managing Director said "Panthera Resources continues to focus its efforts in securing the necessary approvals and licences for the Company's flagship asset, the multi-million ounce Bhukia gold project in India. We appreciate the commitment from our shareholders and directors as the Company moves forward in this challenging investment climate."

 

 

Enquiries

 

Panthera Resources PLC

Mark Bolton (Managing Director) +61 411 220 942

 

Nominated Advisor and Broker

 

RFC Ambrian +44 (0) 20 3440 6800

Rob Adamson

Bhavesh Patel

Charlie Cryer

 

Market Abuse Regulation (MAR) Disclosure

 

The information communicated in this announcement includes inside information for the purposes of Article 7 of Regulation 596/2014.

 

Annexure

 

1.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

a)

Name:

 

Michael Higgins

b)

Position/Status:

Non Executive Chairman

 

c)

Initial notification/ Amendment:

 

Initial notification

 

2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted:

 

a)

Description of the financial instrument, type of instrument:

 

Identification code:

 

[a] Ordinary shares of £0.01 each

[b] Unlisted warrants exercisable at £0.0668 on or before 16 December 2021

[c] Unlisted options (A$0.05, 1/7/2022)

[d] Unlisted options (A$0.20, 6/10/21)

 

[a] 2138001B98EG6736XN82

[b] Not applicable

[c] Not applicable

[d] Not applicable

 

b)

Nature of the transaction:

Shares and options issued for subscription in equity capital raising.

 

c)

Price(s) and Volume(s):

 

 

[a] 705,000 shares at £0.0368

[b] 352,500 warrants at nil cost

[c] Nil Options (A$0.05, 1/7/2022)

[d] Nil Options (A$0.20, 6/10/21)

 

d)

Aggregated Information:

- Aggregated Volume

 

[a] Additional shares in this report: 705,000

[b] Additional warrants in this report: 352,500

[c] Additional Options (A$0.05, 01/07/2022): Nil

[d] Additional Options (A$0.20, 06/10/2021): Nil

 

[a] Updated current shares held: 8,387,808

[b] Updated current warrants held: 352,500

[c] Updated Options (A$0.05, 1/7/2022): 375,000

[d] Updated Options (A$0.20, 1/10/2020): 1,050,000

 

e)

Date of the transaction:

 

15 May 2020

f)

Place of the transaction:

London Stock Exchange

 

 

1.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

a)

Name:

 

Mark Bolton

b)

Position/Status:

Executive Director

 

c)

Initial notification/ Amendment:

 

Initial notification

 

2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted:

 

a)

Description of the financial instrument, type of instrument:

 

Identification code:

 

[a] Ordinary shares of £0.01 each

[b] Unlisted warrants exercisable at £0.0668 on or before 16 December 2021

 

[a] 2138001B98EG6736XN82

[b] Not applicable

 

b)

Nature of the transaction:

Shares and options issued for subscription in equity capital raising.

 

c)

Price(s) and Volume(s):

 

 

[a] 350,000 shares at £0.0368

[b] 175,000 warrants at nil cost

d)

Aggregated Information:

- Aggregated Volume

 

[a] Additional shares in this report: 350,000

[b] Additional warrants in this report: 175,000

 

[a] Updated current shares held: 350,000

[b] Updated current warrants held: 175,000

 

e)

Date of the transaction:

 

15 May 2020

f)

Place of the transaction:

London Stock Exchange

 

1.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

a)

Name:

 

Timothy Hargreaves

b)

Position/Status:

Non Executive Director

 

c)

Initial notification/ Amendment:

 

Initial notification

 

2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted:

 

a)

Description of the financial instrument, type of instrument:

 

Identification code:

 

[a] Ordinary shares of £0.01 each

[b] Unlisted warrants exercisable at £0.0668 on or before 16 December 2021

 

[a] 2138001B98EG6736XN82

[b] Not applicable

 

b)

Nature of the transaction:

Shares and options issued for subscription in equity capital raising.

 

c)

Price(s) and Volume(s):

 

 

[a] 281,848 shares at £0.0368

[b] 140,924 warrants at nil cost

d)

Aggregated Information:

- Aggregated Volume

 

[a] Additional shares in this report: 286,739

[b] Additional warrants in this report: 143,370

 

[a] Updated current shares held: 1,918,534

[b] Updated current warrants held: 143,370

 

e)

Date of the transaction:

 

15 May 2020

f)

Place of the transaction:

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHXELFFBELZBBL
Date   Source Headline
3rd Jun 20267:00 amRNS-ROnline Investor Webinar
29th May 20265:15 pmRNSTotal Voting Rights
21st May 20267:00 amRNSConversion of Options
6th May 20267:00 amRNSConversion of Options
30th Apr 20265:00 pmRNSTotal Voting Rights
14th Apr 20267:09 amRNSConversion of Options
9th Apr 20262:31 pmRNSIssue of Equity – In Lieu of Director Fees
2nd Mar 20267:00 amRNSArbitration Update
19th Jan 20267:00 amRNSBido Drilling Results
31st Dec 202512:45 pmRNSTotal Voting Rights
31st Dec 202512:45 pmRNSTotal Voting Rights
29th Dec 20257:00 amRNSHalf-year Financial Report
29th Dec 20257:00 amRNSHalf-year Financial Report
11th Dec 20257:00 amRNSWarrant Conversion
3rd Dec 20257:00 amRNSWarrant Conversion
1st Dec 20257:00 amRNSTotal Voting Rights
25th Nov 20258:59 amRNSWarrant Conversion
21st Nov 20257:00 amRNSKalaka Metallurgical Study Results
20th Nov 20252:00 pmRNSWarrant Conversion
17th Nov 20257:00 amRNSOTCQB Approval
12th Nov 20257:00 amRNSOTC Application
3rd Nov 202511:02 amRNSIssue of Equity - Warrant Conversion and Fees
31st Oct 20255:05 pmRNSTotal Voting Rights
29th Oct 20257:00 amRNSArbitration Update
16th Oct 20255:05 pmRNSWarrant Conversion
9th Oct 202510:31 amRNSWarrant Conversion
8th Oct 20257:00 amRNSArbitration Financing Facility Update
3rd Oct 202511:30 amRNSResult of AGM
29th Sep 20257:00 amRNSChange of Registered Office
18th Sep 20257:00 amRNSArbitration Update
29th Aug 20255:00 pmRNSTotal Voting Rights
27th Aug 20257:58 amRNS2025 Annual Financial Report
8th Aug 20257:00 amRNSOption Conversion
4th Aug 20257:00 amRNSCommencement of Cascades Feasibility Study
25th Jul 20257:32 amRNSWarrant Conversion
18th Jul 20257:00 amRNSBido Drilling
19th May 20257:00 amRNSUS$1.58 billion Claim for Damages
30th Apr 20255:00 pmRNSTotal Voting Rights
16th Apr 20253:54 pmRNSIssue of Equity - Warrant Conversion and Fees
31st Mar 20255:00 pmRNSTotal Voting Rights
27th Mar 20257:00 amRNSIssue of Equity - Conversion of Options
20th Mar 202510:37 amRNSWarrant Exercise
7th Mar 20255:35 pmRNSNotification of Major Holding
6th Mar 20254:45 pmRNSUpdate on Issue of Equity Fundraising
28th Feb 20255:32 pmRNSNotification of Major Holding
25th Feb 20257:47 amRNSResult of Placing and Subscription
24th Feb 20255:04 pmRNSIssue of Equity
21st Feb 20255:00 pmRNSWarrant Exercise
20th Feb 20256:11 pmRNSNotifications of Major Holdings
4th Feb 20257:00 amRNSMaiden JORC Resource Estimate for Kalaka Project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.